{"page":"https://casescribe.ai/explorer/regulation-changes/2018-05-07","generated_at":"2026-10-03T18:29:26.088Z","data_as_of":{"decisions":944125,"first_year":2017,"last_year":2026,"latest_decision":"2026-04-30","cfr":"2026-10-01","m21":"2026-09-29"},"about":{"publisher":"CaseScribe AI (VA Law Explorer)","source":"Public Board of Veterans' Appeals decisions (appeals of VA decisions, not VA's first decisions), M21-1 Adjudication Procedures Manual, 38 CFR Parts 3 and 4.","method":"Outcomes are issue-level: each condition the Board decided in a decision counts once. Decision data is extracted by AI and can contain errors. Rates describe past appeals and do not predict any claim.","disclaimer":"For research only. CaseScribe AI is not a law firm and this is not legal advice. Verify figures against the source decisions and regulations.","attribution":"Cite as: VA Law Explorer, CaseScribe AI, with the page URL."},"data":{"week_of":"2018-05-07","changes":[{"source":"38 CFR","section":"Schedule of ratings - gynecological conditions and disorders of the breast.","date":"2018-05-13","url":"https://www.ecfr.gov/current/title-38/section-4.116","formatting_only":false,"added":["7610 Vulva or clitoris, disease or injury of (including vulvovaginitis) |","Note:","For the purpose of VA disability evaluation, a disease, injury, or adhesions of the ovaries resulting in ovarian dysfunction affecting the menstrual cycle, such as dysmenorrhea and secondary amenorrhea, shall be rated under diagnostic code 7615 |","Note:","In cases of the removal of one ovary as the result of a service-connected injury or disease, with the absence or nonfunctioning of a second ovary unrelated to service, an evaluation of 30 percent will be assigned for the service-connected ovarian loss |","7621 Complete or incomplete pelvic organ prolapse due to injury, disease, or surgical complications of pregnancy | 10","Note:","Pelvic organ prolapse occurs when a pelvic organ such as bladder, urethra, uterus, vagina, small bowel, or rectum drops (prolapse) from its normal place in the abdomen."],"removed":["Link to an amendment published at 83 FR 15071, Apr.","9, 2018.","7610 Vulva, disease or injury of (including vulvovaginitis).","7621 Uterus, prolapse:","Complete, through vagina and introitus | 50","Incomplete | 30","7622 Uterus, displacement of:","With marked displacement and frequent or continuous menstrual disturbances | 30"]},{"source":"38 CFR","section":"Visual fields.","date":"2018-05-13","url":"https://www.ecfr.gov/current/title-38/section-4.77","formatting_only":false,"added":["The examiner must document the results for at least 16 meridians 22","The examination report must document the results of either the tangent screen or of the 30-degree threshold visual field with the Goldmann III stimulus size.","19, 2009;","83 FR 15320, May 14, 2018]"],"removed":["Link to an amendment published at 83 FR 15320, Apr.","10, 2018.","In all cases, the results must be recorded on a standard Goldmann chart (see Figure 2), and the Goldmann chart must be included with the examination report.","The examiner must chart at least 16 meridians 22","The examination report must then include the tracing of either the tangent screen or of the 30-degree threshold visual field with the Goldmann III stimulus size.","19, 2009]"]},{"source":"38 CFR","section":"Muscle function.","date":"2018-05-13","url":"https://www.ecfr.gov/current/title-38/section-4.78","formatting_only":false,"added":["The examiner must use a Goldmann perimeter chart or the Tangent Screen method that identifies the four major quadrants (upward, downward, left, and right lateral) and the central field (20 degrees or less) (see Figure 2).","The examiner must document the results of muscle function testing by identifying the quadrant(s) and range(s) of degrees in which diplopia exists.","10, 2008, as amended at 83 FR 15320, Apr.","10, 2018]"],"removed":["Link to an amendment published at 83 FR 15321, Apr.","10, 2018.","The examiner must use a Goldmann perimeter chart that identifies the four major quadrants (upward, downward, left and right lateral) and the central field (20 degrees or less) (see Figure 2).","The examiner must chart the areas of diplopia and include the plotted chart with the examination report.","10, 2008]"]},{"source":"38 CFR","section":"Schedule of ratings - eye.","date":"2018-05-13","url":"https://www.ecfr.gov/current/title-38/section-4.79","formatting_only":false,"added":["General Rating Formula for Diseases of the Eye:","Evaluate on the basis of either visual impairment due to the particular condition or on incapacitating episodes, whichever results in a higher evaluation |","With documented incapacitating episodes requiring 7 or more treatment visits for an eye condition during the past 12 months | 60","With documented incapacitating episodes requiring at least 5 but less than 7 treatment visits for an eye condition during the past 12 months | 40","With documented incapacitating episodes requiring at least 3 but less than 5 treatment visits for an eye condition during the past 12 months | 20","With documented incapacitating episodes requiring at least 1 but less than 3 treatment visits for an eye condition during the past 12 months | 10","Note (1):","For the purposes of evaluation under 38 CFR 4.79, an incapacitating episode is an eye condition severe enough to require a clinic visit to a provider specifically for treatment purposes |"],"removed":["Link to an amendment published at 83 FR 15321, Apr.","10, 2018.","6000 Choroidopathy, including uveitis, iritis, cyclitis, and choroiditis.","6006 Retinopathy or maculopathy.","General Rating Formula for Diagnostic Codes 6000 through 6009","Evaluate on the basis of either visual impairment due to the particular condition or on incapacitating episodes, whichever results in a higher evaluation.","With incapacitating episodes having a total duration of at least 6 weeks during the past 12 months | 60","With incapacitating episodes having a total duration of at least 4 weeks, but less than 6 weeks, during the past 12 months | 40"]},{"source":"38 CFR","section":"Special monthly compensation ratings.","date":"2018-05-08","url":"https://www.ecfr.gov/current/title-38/section-3.350","formatting_only":false,"added":["Link to an amendment published at 83 FR 20736, May 8, 2018."],"removed":[]},{"source":"38 CFR","section":"Criteria for determining need for aid and attendance and “permanently bedridden.”","date":"2018-05-08","url":"https://www.ecfr.gov/current/title-38/section-3.352","formatting_only":false,"added":["Link to an amendment published at 83 FR 20737, May 8, 2018."],"removed":[]},{"source":"38 CFR","section":"Adjustment of allowance for aid and attendance.","date":"2018-05-08","url":"https://www.ecfr.gov/current/title-38/section-3.552","formatting_only":false,"added":["Link to an amendment published at 83 FR 20737, May 8, 2018."],"removed":[]}]}}